- Else Nutrition (BABY) has received conditional approval to graduate to the Toronto Stock Exchange
- Final approval is subject to meeting certain conditions of the TSX on or before January 20, 2022
- The company is pursuing the listing to attract institutional capital and increase overall capital markets exposure
- Else Nutrition is focused on developing innovative, clean and plant-based food and nutrition products
- Else Nutrition (BABY) is unchanged trading at $1.53 per share
Else Nutrition (BABY) has received conditional approval to graduate to the Toronto Stock Exchange.
The company would list both its warrants and common shares upon receiving final approval for the listing.
Final approval is subject to meeting certain conditions of the TSX on or before January 20, 2022. If successful, Else’s common shares and warrants would be concurrently delisted from the TSXV.
The trading symbol for the common shares and warrants on the TSX would remain unchanged as BABY, BABY.WT and BABY.WT.A.
Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition, stated,
“This is a significant milestone for the company. We believe the graduation to the TSX, one of the premier exchanges for publicly traded companies, will broaden our reach among institutional investors and improve our access to the capital markets.
Else is at an exciting point in its growth and we are excited to have been elevated to the TSX and look forward to sharing our story and growth strategy with a new audience of international investors.”
Else Nutrition is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products.
Else Nutrition (BABY) is unchanged trading at $1.53 per share as of 9:31 am ET.
